Updated Guideline Moves Genetic Testing Beyond BRCA

Rachel Narozniak, MA
Published: Friday, Mar 13, 2020
Robert Pilarski,
MS, LGC, MSW, LSW

Robert Pilarski, MS, LGC, MSW, LSW

Driven by advances in genetic testing methods and the discovery of actionable mutations beyond BRCA, an update to the National Comprehensive Cancer Network’s (NCCN’s) Guidelines for genetic testing in breast, ovarian, and pancreatic cancers encompasses a much broader range of genes that predict risk for disease occurrence.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x